Presentation Operator Message
Operator (Operator)
Good day, ladies and gentlemen, and welcome to the Altimmune Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, this
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.035 USD | -0.37% |
|
+1.77% | +11.63% |
| 01-05 | Altimmune, Inc. Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH | CI |
| 01-05 | Altimmune Says US FDA Grants Breakthrough Therapy Designation for Pemvidutide in MASH | MT |
Published on 02/27/2025 at 08:30 am EST
Presentation Operator Message
Operator (Operator)
Good day, ladies and gentlemen, and welcome to the Altimmune Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, this
Select your edition
All financial news and data tailored to specific country editions